X

Unlock informed decision-making with DataM's expert pharmaceutical competitive intelligence services.

Definition of Competitive Intelligence

Process of gathering and analyzing information about competitors. Ethical and legal strategies to inform business decisions. Continuous monitoring of market trends and competitor activities.

Importance in Pharma Industry

  • Helps in understanding competitor drug pipelines and R&D focus.
  • Aids in identifying potential market opportunities and threats.
  • Supports regulatory strategy and market entry decisions.

Key Components of Competitive Intelligence

  • Data collection and analysis.
  • Competitive benchmarking and market research.
  • Reporting and actionable insights.

Objectives of DataM’s Competitive Intelligence Solutions

Enhancing Strategic Decision Making

  • Provides actionable insights for informed business strategies.
  • Facilitates evidence-based planning and forecasting.
  • Supports efficient resource allocation.

Driving Innovation and Market Position

  • Identifies emerging trends and technological advancements.
  • Helps in optimizing product development cycles.
  • Enhances competitive edge through strategic market positioning.

Mitigating Market and Competitive Risks

  • Detects early signals of market shifts and disruptions.
  • Monitors competitor actions to preempt threats.
  • Assists in compliance and risk management strategies.

Key Features of DataM’s Solutions

Data Collection Methods

  • Automated data scraping from online sources
  • API integration for real-time data access
  • Sensor and IoT device data collection
  • Manual data entry and validation

Analytical Tools and Technologies

  • Machine learning algorithms for predictive analysis
  • Data visualization tools like Tableau and Power BI
  • Big data processing with Hadoop and Spark
  • SQL and NoSQL databases for data management

Benefits of Real-time Insights

  • Improved decision-making with up-to-date information
  • Ability to detect and respond to trends quickly
  • Enhanced operational efficiency and productivity
  • Competitive advantage through timely insights

Conference Coverage for Pharma Companies

Networking Opportunities

  • Face-to-Face interactions with industry leaders
  • Building relationships with potential partners
  • Opportunities for collaboration and alliances

Knowledge Sharing Platforms

  • Exchange of innovative ideas and best practices
  • Presentation of latest research and developments
  • Insight from thought leaders and experts

Innovations and Breakthroughs Presentations

  • Showcasing cutting-edge technologies and products
  • Discussions on novel treatment methodologies
  • Highlighting significant research outcomes

Benefits for Pharma Companies

Timely Strategic Intelligence

  • Access to real-time data on market dynamics
  • Informed decision-making through actionable insights
  • Anticipating competitor moves and trends

Better Market Positioning

  • Identification of unique selling propositions (USPs)
  • Tailoring of marketing strategies to highlight strengths
  • Strengthening brand perception and loyalty

Improved Product Lifecycle Management

  • Streamlined processes from development to launch
  • Efficient management of product portfolios
  • Prolonging product longevity through timely updates

DataM Case Studies

Background & Objectives

Top pharmaceutical company (US) sought to evaluate the market potential opportunities for their key oncology brand drug across six global markets: China, Brazil, Korea, Russia, Canada, and Mexico

DataM's Role & Approach

  • DataM performed a detailed overview of the disease landscape for each international market using internal data, secondary research, epidemiological insights, and third-party sales data
  • This approach, complemented by a literature review, refined and tailored the data for the revenue model, producing country-specific revenue forecasts based on secondary research

Outcome & Impact

The data enabled the company to understand the opportunities in the China, Brazil, Korea, Russia, Canada, and Mexico based on the provided countrylevel analysis/insights